Quite often viewed as the modern era in chemical manufacturing, continuous manufacturing has been gaining steam over the past few years as a means to manufacture drugs more efficiently, ensure safety and bring products to market faster. While batch manufacturing has been the go-to method of chemical manufacturing, times are changing and more and more Contract Development and Manufacturing Organizations (CDMOs) are considering continuous, or flexible manufacturing alternatives. This new method is getting lots of attention lately, because of its claims to provide cost savings, as well as improved quality and efficiency. But, while there seems to be great promise for continuous manufacturing the jury is still out, since it still is in the early stages of use, with only a handful of commercialized drug products having been manufactured using this method. Reinforcing the interest in the nascent field of continuous manufacturing, this past August, the FDA awarded three grants to universities, using its authority under the 21st Century Cures Act, to study and recommend improvements for the continuous manufacturing of drugs and biological products But as with most things, there is a time and a place for everything, and while continuous manufacturing is growing in importance, it’s no time to send batch processing to pasture quite yet. Each method has benefits and drawbacks. Click Here For Complete Abstract Text
|
||||||||||||||||||
| Application Sequencing | ||||||||||||||||||
|
||||||||||||||||||
| Company | Product | Process | Other Subjects | Event | Event Date | Location | Publication | Publication Date | Text Descriptor | |||||||||
|
|
|
|
|
|
|
||||||||||||